Dallah healthcare holding announced today on tadawul that the third extraordinary general assembly meeting was held on 21/4/2013 to approve amending its corporate objectives by adding the following new objective:
- Manufacturing and packaging of drugs, pharmaceutical and herbal formulas, cosmetics, detergents and disinfectants.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}